Skip to content
sellWeak

Orbimed Advisors LLC sold $900k of PMVP

owner at PMV Pharmaceuticals, Inc.. 500,000 shares at an average of $1.80, traded Sep 10, 2025, filed Sep 12, 2025.

Warning score
36
Value
$900k
500,000 shares
Holdings after
5,975,291
-8% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    10% owner
    +12
  • Trade size
    $900k at market
    +24
  • Share of holdings sold
    Sold 7.7% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0000947871-25-000854, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 10, 2025SOpen-market sale
Common Stockindirect: See Footnotes
-500,000$1.80$900k5,975,291Sep 12, 2025

Related signals

Other insiders at PMV Pharmaceuticals, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
52Moderate
PMVPsell 4
PMV Pharmaceuticals, Inc.
Michael Carulli
Chief Financial Officer
$30k
28,249 shares
-32%
46Moderate
PMVPsell 4
PMV Pharmaceuticals, Inc.
Deepika Jalota
Chief Development Officer
$35k
33,065 shares
-27%
47Moderate
PMVPsell 4
PMV Pharmaceuticals, Inc.
David Henry Mack
President and CEO
$62k
58,411 shares
-10%
40Moderate
PMVPsell 4
PMV Pharmaceuticals, Inc.
Robert Ticktin
General Counsel & COO
$25k
23,151 shares
-19%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Orbimed Advisors LLC sold $900k of PMVP | InsiderTell